European regulators have given Abbott Laboratories CE mark approval for its Alinity hq hematology analyzer, an instrument that comes as part of a planned integrated hematology platform intended for addressing high-volume laboratories' productivity needs. The analyzer allows for automation of hematology tests' performance and provides reports on 29 various parameters in a span of minutes.
EU OKs Abbott's Alinity hq hematology analyzer
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.